Steve Glazer

Director, New Research Programs at ILiAD Biotechnologies

Steve Glazer, M.D. is Director of New Research Programs investigating the role of Bordetella pertussis infection in autoimmune, allergic, and neurodegenerative disease. Dr. Glazer has published scientific papers on the pertussis hypothesis of multiple sclerosis, celiac disease, and Alzheimer’s disease with Dr. Rubin. Dr. Glazer is board certified in internal medicine, and completed postgraduate training at New York-Presbyterian/Cornell, Memorial Sloan Kettering Cancer Center, and was a fellow in General Internal Medicine at New York-Presbyterian/Columbia. Dr. Glazer received his M.D. from Emory University and his B.A. from the University of Pennsylvania.


Org chart